STOK
USDStoke Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$25.000
High
$25.550
Low
$24.660
Volume
0.81M
Company Fundamentals
Market Cap
1.4B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
1.17M
Exchange
NMS
Currency
USD
52-Week Range
AI Analysis Report
Last updated: Oct 30, 2025Stoke Therapeutics (STOK): Riding Wave of Biotech Optimism, But Risks Lurk
Price Action: Volatility With Clear Upside Momentum
The stock has swung between $12.40 and $38.69 over the past 90 days, reflecting high sensitivity to news. Key patterns:
- Explosive breakout in October (up 34% from $20.68 to $27.31 in 4 days, then a dramatic spike to $38.69 on Oct 16)
- Recent correction (-4.3% from Oct 22 to 29) followed by a small rebound on Oct 30 (closing at $31.66 vs. $31.41 open)
- Volume surged to 4x average during the October rally, showing strong institutional interest
News Impact: Positive Clinical Data Drives Surge
Three catalysts fueled the October rally:
Related News
BTIG Reiterates Buy on Stoke Therapeutics, Maintains $39 Price Target
BTIG analyst Thomas Shrader reiterates Stoke Therapeutics with a Buy and maintains $39 price target.
JP Morgan Maintains Neutral on Stoke Therapeutics, Raises Price Target to $25
JP Morgan analyst Jessica Fye maintains Stoke Therapeutics with a Neutral and raises the price target from $15 to $25.
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates
Stoke Therapeutics, Inc. (NASDAQ:STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen, in
AI PredictionBeta
AI Recommendation
Updated at: Nov 5, 2025, 09:53 AM
69.8% Confidence
Risk & Trading
Entry Point
$29.88
Take Profit
$32.14
Stop Loss
$27.01
Key Factors
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.